Imaging Advances in Stroke: Use of Advanced Neurovascular Imaging or Disruptive Innovation With Artificial Intelligence?

Abstract

Authors

• David S Liebeskind
  From the Biocomplexity Institute (V.A., R.Z.), Department of Industrial and Systems Engineering (G.T.), and Nutritional Immunology and Molecular Medicine Laboratory, Biocomplexity Institute (R.H., J.B.-R.), Virginia Tech, Blacksburg; Biomedical and Translational Informatics Institute (V.A.) and Department of Neurology (R.Z.), Geisinger Health System, Danville, PA; Department of Neurology, University of Tennessee Health Science Center, Memphis (N.G., G.T., L.E., J.E.M., A.W.A., A.V.A., R.Z.); Second Department of Neurology, "Attikon University Hospital," School of Medicine, University of Athens, Greece (N.H.); and Neurovascular Imaging Research Core and UCLA Stroke Center, University of California, Los Angeles (D.S.L.).
• Joanna M Wardlaw
  Department of Neuroimaging Sciences, Centre for Clinical Brain Sciences, University of Edinburgh, Edinburgh, United Kingdom.

Keywords

External Resources